Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 13.82%70.06B | 15.09%301.88B | -2.91%86.51B | 29.88%79.83B | 20.97%73.98B | 21.71%61.56B | -54.73%262.3B | 25.81%89.11B | -59.60%61.46B | -64.12%61.16B |
Cost of revenue | 11.15%58.77B | 12.98%254.63B | 4.05%73.51B | 36.69%66.25B | 10.80%62.01B | 5.11%52.87B | -59.07%225.38B | 10.86%70.65B | -66.83%48.47B | -66.67%55.97B |
Gross profit | 30.06%11.29B | 27.95%47.24B | -29.54%13.01B | 4.47%13.58B | 130.62%11.97B | 3,057.82%8.68B | 28.42%36.92B | 160.12%18.46B | 115.45%13B | 100.85%5.19B |
Operating expense | 0.43%6.99B | 0.23%27.61B | 4.83%6.86B | -4.12%6.74B | 0.73%7.05B | -0.19%6.96B | -28.97%27.55B | -15.11%6.54B | -35.85%7.03B | -28.86%7B |
Operating profit | 150.00%4.3B | 109.38%19.63B | -48.41%6.15B | 14.60%6.84B | 373.12%4.93B | 125.66%1.72B | 193.48%9.38B | 2,050.57%11.92B | 220.97%5.96B | 75.11%-1.8B |
Net non-operating interest income (expenses) | 14.15%-819M | -49.18%-3.73B | -62.40%-812M | -36.93%-953M | -40.50%-1.01B | -63.08%-954M | -332.06%-2.5B | 11.97%-500M | -248.40%-696M | -203.77%-716M |
Non-operating interest income | 56.86%80M | 46.61%563M | 7.67%309M | 159.46%96M | 322.92%107M | -52.78%51M | -89.87%384M | 1,535.00%287M | -96.94%37M | -103.56%-48M |
Non-operating interest expense | -10.55%899M | 48.84%4.29B | 42.44%1.12B | 43.11%1.05B | 66.62%1.11B | 45.02%1.01B | 6.19%2.88B | 43.61%787M | -1.21%733M | 1.52%668M |
Net investment income | -43.80%476M | -79.90%969M | 726.00%313M | 93.88%-209M | -99.56%18M | -79.79%847M | 263.10%4.82B | -103.33%-50M | -2,110.00%-3.42B | 468.53%4.1B |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | 116.38%412M | 101.93%42M | 108.52%19M | |||||
Income from associates and other participating interests | 828.66%3.48B | 73.20%6.6B | 98.60%4.25B | 1,418.52%1.07B | -32.00%1.76B | 42.69%-478M | 126.02%3.81B | 112.69%2.14B | 94.41%-81M | 75.42%2.58B |
Special income (charges) | 1,200.93%25.29B | -107.28%-221M | -10,260.00%-3.56B | 458.04%2.67B | -385.52%-1.28B | -6.22%1.94B | -72.44%3.04B | -98.03%35M | -72.26%479M | -82.67%449M |
Less:Restructuring and mergern&acquisition | --0 | ---1.32B | --627M | ---627M | --627M | ---1.94B | --0 | --0 | --0 | --0 |
Less:Other special charges | ---25.29B | 102.80%85M | 4,317.14%1.48B | -327.14%-2.05B | ---- | ---- | 72.64%-3.04B | 98.07%-35M | 72.30%-479M | 82.95%-449M |
Less:Write off | ---- | --1.45B | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Other non-operating income (expenses) | 107.09%92M | -28.76%-3.84B | -66.23%-881M | -42.80%-1.05B | 56.89%-607M | -324.18%-1.3B | 14.17%-2.98B | 2.21%-530M | -32.37%-736M | 51.08%-1.41B |
Income before tax | 1,742.90%32.82B | 21.50%19.42B | -58.15%5.47B | 445.89%8.36B | 7.09%3.81B | 182.34%1.78B | 192.68%15.98B | 174.60%13.06B | 131.50%1.53B | 156.57%3.55B |
Income tax | 1,150.94%4B | -1,741.94%-5.91B | -1,689.09%-8.03B | -22.72%592M | 299.34%1.21B | 223.08%320M | -95.43%360M | -117.48%-449M | -57.84%766M | 133.52%303M |
Net income | 1,872.48%28.82B | 62.16%25.33B | -0.05%13.5B | 914.62%7.77B | -20.13%2.6B | 176.81%1.46B | 162.18%15.62B | 167.29%13.51B | 111.47%766M | 160.40%3.25B |
Net income continuous operations | 1,872.55%28.82B | 62.14%25.33B | -0.06%13.5B | 914.49%7.77B | -20.15%2.6B | 176.77%1.46B | 162.19%15.62B | 167.29%13.51B | 111.47%766M | 160.44%3.25B |
Noncontrolling interests | 169.44%25M | 323.08%275M | -32.53%112M | 408.57%108M | 321.95%91M | -44.00%-36M | 101.97%65M | 191.71%166M | 98.35%-35M | 98.22%-41M |
Net income attributable to the company | 1,823.38%28.79B | 61.06%25.05B | 0.35%13.39B | 856.80%7.66B | -23.91%2.5B | 179.75%1.5B | 171.27%15.55B | 167.06%13.34B | 117.55%801M | 206.82%3.29B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 1,823.38%28.79B | 61.06%25.05B | 0.35%13.39B | 856.80%7.66B | -23.91%2.5B | 179.75%1.5B | 171.27%15.55B | 167.06%13.34B | 117.55%801M | 206.82%3.29B |
Gross dividend payment | ||||||||||
Basic earnings per share | 1,803.96%283.69 | 44.10%255.73 | -12.17%136.43 | 980.98%79.02 | -32.84%25.38 | 164.90%14.9 | 165.74%177.47 | 163.14%155.33 | 112.94%7.31 | 199.16%37.79 |
Diluted earnings per share | 1,823.74%283.56 | 45.45%254.42 | -11.21%135.93 | 990.01%78.59 | -33.42%25.16 | 164.20%14.74 | 164.80%174.92 | 162.23%153.1 | 112.77%7.21 | 199.16%37.79 |
Dividend per share | 0 | 66.67%5 | 66.67%5 | 0 | 0 | 0 | 3 | 3 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |